InnovAge Holding Corp. Common Stock (INNV) is a publicly traded Healthcare sector company. As of November 18, 2026, INNV trades at $8.87 with a market cap of $1.29B and a P/E ratio of -456.75. INNV moved -7.01% today. Year to date, INNV is +71.99%; over the trailing twelve months it is +89.64%. Its 52-week range spans $2.60 to $12.64. Analyst consensus is neutral with an average price target of $12.00. Rallies surfaces INNV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover INNV: 0 strong buy, 1 buy, 1 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $12.00.
| Metric | Value |
|---|---|
| Price | $8.87 |
| Market Cap | $1.29B |
| P/E Ratio | -456.75 |
| EPS | $-0.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.64 |
| 52-Week Low | $2.60 |
| Volume | 364.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $989.71M |
| Net Income | $-683.00K |
| Gross Margin | 23.01% |
3 analysts cover INNV: 0 strong buy, 1 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.00.